BSE filing, BSE: 530317. Summary written from the filing by ALFA Finder's alert engine.
Godavari Drugs Ltd: key numbers
- Share price
- ₹125.60
- Market cap
- ₹127.2 Cr
- Revenue (annual)
- ₹105.8 Cr
- Net profit (annual)
- ₹4.09 Cr
- P/E (TTM)
- 30.6×Sector 45.9×
- Promoter holding
- 40.23%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Godavari Drugs Ltd
All →Godavari Drugs Debt & Borrowing: ₹34 Cr
Godavari Drugs Limited's board approved availing working capital limits of Rs. 34 Crore from ICICI Bank. The facility is within existing shareholder-approved borrowing limits.
- Value
- ₹34.00 Cr
Godavari Drugs Annual General Meeting
Godavari Drugs held its 38th Annual General Meeting on September 25, 2026, via video conferencing. Shareholders approved financial statements, director re-appointment, and object clause alteration.
Godavari Drugs Annual General Meeting
Godavari Drugs Limited will close its register of members and share transfer books from September 19 to September 25, 2026, for its 38th Annual General Meeting.
Godavari Drugs Board Meeting Outcome
Godavari Drugs approved altering its Memorandum of Association to add a nutraceuticals business object. A revised notice for the 38th AGM was also approved.
Godavari Drugs Capital Structure Change
Godavari Drugs Limited allotted 7,86,690 equity shares to the promoter category following warrant conversion. The company received Rs. 5.25 Crore, representing the final 75% payment.
- Value
- ₹5.25 Cr
Godavari Drugs Q1 FY27 Results: Net Profit ₹1.1 Cr, Up 10.0% YoY
Godavari Drugs Ltd reported revenue from operations of ₹28 Cr (+17.6% YoY) and net profit of ₹1.1 Cr (+10.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.1 Cr · +10.0% YoY
Other other announcement announcements
All →Donear Industries Other Announcement
Donear Industries Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, under Regulation 31. The filing shows promoter and public holdings only, with no transaction or corporate event.
Meyer Apparel Other Announcement
Meyer Apparel Ltd filed its quarterly shareholding pattern for the quarter ended 30 September 2026. Promoter and promoter group hold 74.32% of the 8,04,97,800 equity shares.
Wipro Other Announcement
Wipro designated person Satyaki Banerjee sold 10,000 ADRs valued at about Rs 0.20 Crore, executed on NYSE. The filing is a Reg 7(2) PIT disclosure of this insider sale.
- Value
- ₹0.20 Cr
Ardee Industries Other Announcement
Ardee Industries' quarterly shareholding pattern for the quarter ended 30 September 2026 shows promoters holding 67.62%. This is a routine Regulation 31 disclosure, not a transaction.
Renaissance Global Other Announcement
Renaissance Global filed its quarterly shareholding pattern for the quarter ended September 30, 2026. This is a routine regulatory disclosure with no transaction or business event.
Jayatma Industries Other Announcement
Jayatma Industries informed BSE that Regulation 23(9) related party transaction disclosures do not apply, as paid-up capital is under ₹10 crore and net worth under ₹25 crore. This is a non-applicability intimation with no transaction or money involved.